About: Effects of bucindolol on neurohormonal activation in congestive heart failure

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Effects of bucindolol on neurohormonal activation in congestive heart failure Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 January 1991

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в січні 1991 (uk) im Januar 1991 veröffentlichter wissenschaftlicher Artikel (de) գիտական հոդված հրատարակված 1991 թվականի հունվարի 1-ին (hy) artículu científicu espublizáu en xineru de 1991 (ast) artikull shkencor i botuar më 01 janar 1991 (sq) scientific article published on 01 January 1991 (en)
publication date	wds:Q68290522-6A2089D3-3333-4DB7-9724-FBAB7ECF8ED6
publication date	1991-01-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q68290522-917690E2-81DA-4EBB-9935-F295ACAEF0B3
language of work or name	English
author name string	wds:Q68290522-21448F06-560A-4E06-86CC-B0D085B72013 wds:Q68290522-411E49D6-48B3-4C39-BC2E-3E02EA3D12AE wds:Q68290522-4CD1B0E5-E6DD-45A8-B863-E99B9DF7112A wds:Q68290522-7E931812-6105-48A5-A3B8-ACCB2BFD9DB7 wds:Q68290522-AEE52527-2384-40DE-87EB-BA4D90C5C6C0 wds:Q68290522-BE053CC1-73F9-4BDE-AD67-1CF054974248 wds:Q68290522-D36D3B6B-38A3-4F64-A374-3EFBE53B3DE9 wds:Q68290522-DCD4A022-1112-4EA4-8CBC-DAA6D4B555C3 wds:Q68290522-EEC8E879-8B1F-4525-8402-4979A4715096
author name string	J B Bedotto J R Corbett P A Grayburn J E Willard C R Malloy E J Eichhorn B A Hatfield D Deitchman A L McGhie
rdfs:label	Effects of bucindolol on neurohormonal activation in congestive heart failure (en) Effects of bucindolol on neurohormonal activation in congestive heart failure (nl) Effects of bucindolol on neurohormonal activation in congestive heart failure (sq)
skos:prefLabel	Effects of bucindolol on neurohormonal activation in congestive heart failure (en) Effects of bucindolol on neurohormonal activation in congestive heart failure (nl) Effects of bucindolol on neurohormonal activation in congestive heart failure (sq)
name	Effects of bucindolol on neurohormonal activation in congestive heart failure (en) Effects of bucindolol on neurohormonal activation in congestive heart failure (nl) Effects of bucindolol on neurohormonal activation in congestive heart failure (sq)
author	wds:Q68290522-4A1E5FAE-EEF2-4065-B07D-D4F4592C8E02
author	Craig R Malloy
title	wds:Q68290522-BB824DC3-4FE5-47B8-8A2B-113C2C1CEE27
title	Effects of bucindolol on neurohormonal activation in congestive heart failure (en)
page(s)	wds:Q68290522-C0494053-3071-48DC-B346-E3D3365FC30F
page(s)	67-73
instance of	wds:Q68290522-484D2C74-BE17-48F5-BFB6-85E4C7FD99C5
instance of	scholarly article
main subject	wds:Q68290522-92A01583-264A-4C63-B3CC-4A28E28CF37F
main subject	congestive heart failure
PubMed ID	wds:Q68290522-4D1F700D-7351-4957-920E-7AA0E1DE8890
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/1670902
PubMed ID	1670902
published in	wds:Q68290522-B88802E8-290B-49DD-9328-E6E3E6AB3F61
published in	American Journal of Cardiology
issue	wds:Q68290522-B7381DB3-68C4-4675-8BFA-3D8324AB6B1C
volume	wds:Q68290522-044E882E-3D73-49CE-982A-148D5D140C6E
issue	1
volume	67
DOI	wds:Q68290522-F60C9587-10F2-4C54-9673-2EEBE89BDEFE
DOI	http://dx.doi.org/10.1016/0002-9149(91)90102-Q
DOI	10.1016/0002-9149(91)90102-Q
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q68290522
is cites work of	Prognostic significance of cardiac (123)I metaiodobenzylguanidine imaging for mortality and morbidity in patients with chronic heart failure: a prospective study Cardiac metaiodobenzylguanidine uptake in patients with moderate chronic heart failure: relationship with peak oxygen uptake and prognosis Adrenergic and muscarinic receptor regulation and therapeutic implications in heart failure Restoring function in failing hearts: the effects of beta blockers A Comparison of Vasodilating and Non-vasodilating Beta-Blockers and Their Effects on Cardiometabolic Risk No-carrier-added versus carrier-added123I-metaiodobenzylguanidine for the assessment of cardiac sympathetic nerve activity. Beta-blocker use in decompensated heart failure Improvement in left ventricular function in response to carvedilol is accompanied by attenuation of neurohumoral activation in patients with dilated cardiomyopathy Effect of bisoprolol on QT dispersion in patients with congestive heart failure--the etiology-dependent response Beneficial effects of carvedilol on angiotensin-converting enzyme activity and renin plasma levels in patients with chronic heart failure The sympathetic nervous system and the renin-angiotensin-aldosterone system in cardiovascular disease Early reduction of neurohumoral factors plays a key role in mediating the efficacy of beta-blocker therapy for congestive heart failure Chronic beta-blocker treatment in patients with advanced heart failure The control of adrenergic function in heart failure: therapeutic intervention. Long-term effect of atenolol on ejection fraction, symptoms, and exercise variables in patients with advanced left ventricular dysfunction Normal values and within-subject variability of cardiac I-123 MIBG scintigraphy in healthy individuals: implications for clinical studies Sympatholysis and cardiac sympathetic nerve function in the treatment of congestive heart failure. Influence of collimator choice and simulated clinical conditions on 123I-MIBG heart/mediastinum ratios: a phantom study Efficacy of Carvedilol in Patients with Dilated Cardiomyopathy due to Beta-thalassemia major; a Double-blind Randomized Controlled Trial Medical therapy of chronic heart failure. Role of ACE inhibitors and beta-blockers Cell death in the failing heart: role of an unnatural growth response to overload. Beta adrenergic blockers lower renin in patients treated with ACE inhibitors and diuretics Beta-blocker therapy in heart failure: pathophysiology and clinical results Effects of beta-blockers on neurohormonal activation in patients with congestive heart failure Beta-blocker benefit according to severity of heart failure. Effect of race in the response to metoprolol in patients with congestive heart failure secondary to idiopathic dilated or ischemic cardiomyopathy Medical therapy and prognosis in chronic heart failure. Lessons from clinical trials. Baseline Serum Aldosterone-to-Renin Ratio is Associated with the Add-on Effect of Thiazide Diuretics in Non-Diabetic Essential Hypertensives Selective or nonselective β-adrenergic blockade in patients with congestive heart failure Neurohormonal Therapy for Congestive Heart Failure Beta blockers in heart failure haemodynamics, clinical effects and modes of action
is cites work of	wds:Q28364276-2AEBE172-77EE-4CEF-BC58-4238AEB94284 wds:Q36574992-D605D7B5-C8D2-4C99-9D50-B0E9135EDEC7 wds:Q44925680-2EE5207E-3F49-4204-8E9C-1DE6EE35B589 wds:Q39413028-A8A731BC-6064-4D3D-8AC9-B0226D24047A wds:Q77802846-2D46CE6B-7EEA-4645-ACA0-D28A690E83DF wds:Q35368520-B76877BC-4A08-451E-B4D8-FA11AA44BB1A wds:Q33685814-A75C1D8B-C3B7-4953-95C4-AEEB4D07E58C

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software